Xeljanz XR 11 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FNVAX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,184
Award facts
- Contract value 100% obligated
- $27,184.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $27,184.05 to AmerisourceBergen Drug Corp for XELJANZ XR 11 mg tablets (30-count units) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. XELJANZ XR is a prescription medication used to treat inflammatory conditions, and this delivery order represents a routine pharmaceutical procurement supporting federal medical supply chain operations.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, medical devices, and related healthcare commodities to support military and federal healthcare programs worldwide. AmerisourceBergen Drug Corp's federal procurement activity demonstrates significant capability in fulfilling diverse pharmaceutical requirements across multiple therapeutic domains for defense and civilian federal agencies, including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DB25FNVAX?
SPE2DB25FNVAX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 22, 2025.
How much is contract SPE2DB25FNVAX worth?
The government has obligated $27,184 on SPE2DB25FNVAX.
Is contract SPE2DB25FNVAX an order under another contract?
Yes. SPE2DB25FNVAX is a delivery order under SPE2DB25D3201, an indefinite delivery contract.
Was contract SPE2DB25FNVAX competed?
The extent of competition for SPE2DB25FNVAX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award